O Shaughnessy Asset Management LLC Sells 2,800 Shares of Fresenius Medical Care AG (NYSE:FMS)

O Shaughnessy Asset Management LLC reduced its position in shares of Fresenius Medical Care AG (NYSE:FMS) by 7.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 33,678 shares of the company’s stock after selling 2,800 shares during the period. O Shaughnessy Asset Management LLC’s holdings in Fresenius Medical Care were worth $762,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in FMS. Callan Family Office LLC bought a new position in shares of Fresenius Medical Care in the fourth quarter valued at approximately $502,000. Callan Capital LLC bought a new position in Fresenius Medical Care in the 4th quarter valued at $297,000. Sanctuary Advisors LLC acquired a new position in Fresenius Medical Care in the fourth quarter worth $983,000. ABC Arbitrage SA bought a new stake in shares of Fresenius Medical Care during the fourth quarter worth $4,215,000. Finally, Verition Fund Management LLC acquired a new stake in shares of Fresenius Medical Care in the third quarter valued at $237,000. 8.37% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of brokerages have commented on FMS. StockNews.com raised shares of Fresenius Medical Care from a “hold” rating to a “strong-buy” rating in a report on Wednesday, February 5th. Truist Financial raised their price target on shares of Fresenius Medical Care from $23.00 to $25.00 and gave the company a “hold” rating in a report on Monday, January 6th.

Fresenius Medical Care Price Performance

Fresenius Medical Care stock opened at $22.53 on Wednesday. The business’s 50-day simple moving average is $24.02 and its 200 day simple moving average is $22.71. The company has a quick ratio of 1.02, a current ratio of 1.37 and a debt-to-equity ratio of 0.42. The stock has a market cap of $13.22 billion, a price-to-earnings ratio of 18.62, a P/E/G ratio of 0.76 and a beta of 0.93. Fresenius Medical Care AG has a 12-month low of $17.93 and a 12-month high of $25.96.

Fresenius Medical Care Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.